Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift? - Chatzidionysiou K; Liapi M; Tsakonas G; Gunnarsson I; Catrina A (Clinical rheumatology, 2021)